Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.
Maiti P, Manna J, Dunbar GL. · 2017
Read Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments. by Maiti P, Manna J, Dunbar GL. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5655877.txt.
Introduction
Maiti and co-authors review what drives Parkinson's disease at the molecular level. Their review centers on the slow loss of dopamine neurons in a brain area called the substantia nigra. That loss cuts dopamine in the striatum and brings on motor problems. Current drugs ease symptoms for a time but do not stop the disease.
The review covers genetic and environmental factors that may start the process. It explains protein misfolding, chaperones, and the cell systems that clear bad proteins. Two such systems are autophagy and the proteasome. The authors then survey new options, from drugs and surgery to stem cells and gene therapy.
Catalog record
| CREATOR | Maiti P, Manna J, Dunbar GL. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 157 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |